mhurhangee/ep-ind-claims huggingface dataset:
A hybridization composition comprising at least one in situ hybridization probe, about 1%-95% (v/v) of at least one polar aprotic solvent having cyclic base structure in an amount effective to denature double-stranded nucleotide sequences, and a hybridization solution comprising at least one additional component selected from the group consisting of: buffering agents, salts, accelerating agents, chelating agents, detergents, and blocking agents, wherein the polar aprotic solvent is selected from the group consisting of:
A method of audio coding comprising: receiving a first value of a mixing factor, the first value based on low-band voicing parameters of a first portion of an audio signal; receiving a second value of the mixing factor, the second value based on low-band voicing parameters of a second portion of the audio signal; generating a third value of the mixing factor at least partially based on the first value, the second value, and high-band energy fluctuation of the audio signal; and generating a high-band excitation signal corresponding to a high-band portion of the audio signal, wherein the high-band excitation signal is generated based on mixing an excitation signal with modulated noise based on the third mixing factor, wherein the excitation signal corresponds to a transformed version of a low-band excitation signal, the low-band excitation signal corresponding to a low-band portion of the audio signal. receiving a first value of a mixing factor, the first value based on low-band voicing parameters of a first portion of an audio signal; receiving a second value of the mixing factor, the second value based on low-band voicing parameters of a second portion of the audio signal; generating a third value of the mixing factor at least partially based on the first value, the second value, and high-band energy fluctuation of the audio signal; and generating a high-band excitation signal corresponding to a high-band portion of the audio signal, wherein the high-band excitation signal is generated based on mixing an excitation signal with modulated noise based on the third mixing factor, wherein the excitation signal corresponds to a transformed version of a low-band excitation signal, the low-band excitation signal corresponding to a low-band portion of the audio signal.
A catalyst for producing at least one of an unsaturated aldehyde compound, an unsaturated carboxylic acid compound, and a conjugated diene comprising molybdenum; bismuth; and cobalt, wherein a composition of a catalytically active component is represented by the following formula (I-1): Mo a1 Bi b1 Ni c1 Co d1 Fe e1 X f1 Y g1 Z h1 O i1... (I-1) wherein in the formula, Mo, Bi, Ni, Co and Fe represent molybdenum, bismuth, nickel, cobalt and iron, respectively; X is at least one element selected from tungsten, antimony, tin, zinc, chromium, manganese, magnesium, silicon, aluminum, cerium and titanium; Y is at least one element selected from sodium, potassium, cesium, rubidium, and thallium; Z belongs to the 1st to 16th groups in the periodic table and means at least one element selected from elements other than the above Mo, Bi, Ni, Co, Fe, X, and Y; a1, b1, c1, d1, e1, f1, g1, h1, and i1 represent the number of atoms of molybdenum, bismuth, nickel, cobalt, iron, X, Y, Z, and oxygen, respectively; when a1 = 12, 0 < b1 ≤ 7, 0 ≤ c1 ≤ 10, 0< d1 ≤ 6.3, 0 < c1 + d1 ≤ 20, 0 ≤ e1 ≤ 5, 0 ≤ f1 ≤ 2, 0 ≤ g1 ≤ 3, 0 ≤ h1 ≤ 5, and i1 is a value determined by an oxidation state of each element, and wherein a sum of ratios of peak intensities expressed by the following formula in an X-ray diffraction pattern obtained by using CuKα rays as an X-ray source is 42 or more and 95 or less. S = {(peak intensity at 2θ = 14.1° ± 0.1°) + (peak intensity at 2θ = 25.4° ± 0.1°) + (peak intensity at 2θ = 28.5° ± 0.1°)}/(peak intensity at 2θ = 26.5° ± 0.1°) × 100 molybdenum; bismuth; and cobalt, wherein a composition of a catalytically active component is represented by the following formula (I-1): Mo a1 Bi b1 Ni c1 Co d1 Fe e1 X f1 Y g1 Z h1 O i1... (I-1) wherein in the formula, Mo, Bi, Ni, Co and Fe represent molybdenum, bismuth, nickel, cobalt and iron, respectively; X is at least one element selected from tungsten, antimony, tin, zinc, chromium, manganese, magnesium, silicon, aluminum, cerium and titanium; Y is at least one element selected from sodium, potassium, cesium, rubidium, and thallium; Z belongs to the 1st to 16th groups in the periodic table and means at least one element selected from elements other than the above Mo, Bi, Ni, Co, Fe, X, and Y; a1, b1, c1, d1, e1, f1, g1, h1, and i1 represent the number of atoms of molybdenum, bismuth, nickel, cobalt, iron, X, Y, Z, and oxygen, respectively; when a1 = 12, 0 < b1 ≤ 7, 0 ≤ c1 ≤ 10, 0< d1 ≤ 6.3, 0 < c1 + d1 ≤ 20, 0 ≤ e1 ≤ 5, 0 ≤ f1 ≤ 2, 0 ≤ g1 ≤ 3, 0 ≤ h1 ≤ 5, and i1 is a value determined by an oxidation state of each element, and wherein a sum of ratios of peak intensities expressed by the following formula in an X-ray diffraction pattern obtained by using CuKα rays as an X-ray source is 42 or more and 95 or less. S = {(peak intensity at 2θ = 14.1° ± 0.1°) + (peak intensity at 2θ = 25.4° ± 0.1°) + (peak intensity at 2θ = 28.5° ± 0.1°)}/(peak intensity at 2θ = 26.5° ± 0.1°) × 100
An in vitro method of fragmenting and tagging target DNA, comprising incubating target DNA with: (i) a transposase; and (ii) a transposon end composition comprising a transferred strand that exhibits, in its 5' portion, the sequence of a tag domain that is not a transposon end, and, in its 3' portion, the sequence of the transferred transposon end, wherein: a) said target DNA is fragmented; and b) said transferred strand of said transposon end composition is joined to a 5' end of a fragment of said target DNA to produce a 5' tagged target DNA fragment. (i) a transposase; and (ii) a transposon end composition comprising a transferred strand that exhibits, in its 5' portion, the sequence of a tag domain that is not a transposon end, and, in its 3' portion, the sequence of the transferred transposon end, a) said target DNA is fragmented; and b) said transferred strand of said transposon end composition is joined to a 5' end of a fragment of said target DNA to produce a 5' tagged target DNA fragment.
A computer-implemented method for configuring an MRI system, the method comprising: - providing a set of one or more parameters (122, 322) for configuring the MRI system, each parameter of the set having predefined values; - selecting from the predefined values a set of values of the set of parameters; - setting the set of parameters using the selected set of values, resulting in an operational configuration of the MRI system; - controlling the MRI system to operate in accordance with the operational configuration, thereby determining an operating status of the MRI system, wherein the steps of selecting, setting and controlling are repeated for mulitple patients and wherein the selected set of values is different for different patients; - repeatedly performing the selecting, setting and controlling until a desired operating status of the MRI system can be determined based on the operating statuses resulting from the controlling and selecting and setting of the set of parameters for multiple patients. - providing a set of one or more parameters (122, 322) for configuring the MRI system, each parameter of the set having predefined values; - selecting from the predefined values a set of values of the set of parameters; - setting the set of parameters using the selected set of values, resulting in an operational configuration of the MRI system; - controlling the MRI system to operate in accordance with the operational configuration, thereby determining an operating status of the MRI system, wherein the steps of selecting, setting and controlling are repeated for mulitple patients and wherein the selected set of values is different for different patients; - repeatedly performing the selecting, setting and controlling until a desired operating status of the MRI system can be determined based on the operating statuses resulting from the controlling and selecting and setting of the set of parameters for multiple patients.
An acoustic wave filter device comprising: a piezoelectric substrate; and a plurality of longitudinally coupled resonator acoustic wave filters (7,8) provided on the piezoelectric substrate, wherein each of the longitudinally coupled resonator acoustic wave filters (7,8) includes an input terminal, an output terminal, an IDT connected to the input terminal, and an IDT connected to the output terminal, the IDT connected to the input terminal and the IDT connected to the output terminal being alternately provided along an acoustic wave propagating direction, the acoustic wave filter device further comprising: a first terminal connected to the input terminals of the plurality of longitudinally coupled resonator acoustic wave filters; and a second terminal connected to the output terminals of the plurality of longitudinally coupled resonator acoustic wave filters, wherein the plurality of longitudinally coupled resonator acoustic wave filters (7,8) are withdrawal-weighted, the withdrawal weighting in at least one of the longitudinally coupled resonator acoustic wave filters (7/8) is different from the withdrawal weighting in the other (8/7) longitudinally coupled resonator acoustic wave filters, and the acoustic wave filter device does not have a balance-to-unbalance transforming function. a piezoelectric substrate; and a plurality of longitudinally coupled resonator acoustic wave filters (7,8) provided on the piezoelectric substrate, wherein each of the longitudinally coupled resonator acoustic wave filters (7,8) includes an input terminal, an output terminal, an IDT connected to the input terminal, and an IDT connected to the output terminal, the IDT connected to the input terminal and the IDT connected to the output terminal being alternately provided along an acoustic wave propagating direction, the acoustic wave filter device further comprising: a first terminal connected to the input terminals of the plurality of longitudinally coupled resonator acoustic wave filters; and a second terminal connected to the output terminals of the plurality of longitudinally coupled resonator acoustic wave filters, a first terminal connected to the input terminals of the plurality of longitudinally coupled resonator acoustic wave filters; and a second terminal connected to the output terminals of the plurality of longitudinally coupled resonator acoustic wave filters, wherein the plurality of longitudinally coupled resonator acoustic wave filters (7,8) are withdrawal-weighted, the withdrawal weighting in at least one of the longitudinally coupled resonator acoustic wave filters (7/8) is different from the withdrawal weighting in the other (8/7) longitudinally coupled resonator acoustic wave filters, and the acoustic wave filter device does not have a balance-to-unbalance transforming function.
A recombinant rabies virus vector (RABV) comprising a nucleotide sequence encoding at least one immunogenic glycoprotein, which glycoprotein is a chimeric protein comprising the S1 domain of the spike protein of Middle East Respiratory Coronavirus (MERS-CoV) and a membrane anchor, which membrane anchor comprises a portion of the RABV glycoprotein, said portion comprising the cytoplasmic domain, the transmembrane domain, and a portion of the ectodomain.
A beverage composition for the preparation of tea that comprises viable Bacillus coagulans spores, wherein preparing said tea comprises combining said composition with boiling water, said composition comprising isolated Bacillus coagulans spores and dehydrated vegetative matter used for brewing tea, wherein said dehydrated vegetative matter is obtained from Camellia sinensis, or from ginger tea, hibiscus tea, rooibos tea, peppermint tea, or stevia tea and wherein (a) the vegetative matter is coated or sprayed with isolated Bacillus coagulans spores; (b) the composition is contained in a tea bag, and isolated Bacillus coagulans spores in the form of a lyophilized, spray-dried, air-dried or frozen powder are included on the surface of the tea bag; or (c) the composition is contained in a tea bag, and isolated Bacillus coagulans spores in the form of a lyophilized, spray-dried, air-dried or frozen powder are included in the tea bag. (a) the vegetative matter is coated or sprayed with isolated Bacillus coagulans spores; (b) the composition is contained in a tea bag, and isolated Bacillus coagulans spores in the form of a lyophilized, spray-dried, air-dried or frozen powder are included on the surface of the tea bag; or (c) the composition is contained in a tea bag, and isolated Bacillus coagulans spores in the form of a lyophilized, spray-dried, air-dried or frozen powder are included in the tea bag.
Method for producing reactive quicklime by thermally processing chalk, wherein • the chalk is formed into compact shaped members having a green strength of > 100 N so that the shaped members have a size of at least 10 mm and a pin-like, oval or spherical or round shape, • the shaped members are brought into a vertical stack which can be constantly flowed through, • the shaped members are subsequently dried in the vertical stack and/or pre-heated and/or pre-calcined and burnt. • the chalk is formed into compact shaped members having a green strength of > 100 N so that the shaped members have a size of at least 10 mm and a pin-like, oval or spherical or round shape, • the shaped members are brought into a vertical stack which can be constantly flowed through, • the shaped members are subsequently dried in the vertical stack and/or pre-heated and/or pre-calcined and burnt.
A method of operating a wind turbine comprising a generator in the event of a voltage dip comprising: detecting an end of the voltage dip; determining an acceleration of a rotor of the generator, increasing a torque of the generator when the end of the voltage dip is detected according to a selected torque profile wherein the selected torque profile is selected from a plurality predetermined torque profiles, wherein the predetermined torque profiles describe torque as a function of time; and wherein the selected torque profile is selected based on the determined acceleration of the rotor of the generator. detecting an end of the voltage dip; determining an acceleration of a rotor of the generator, increasing a torque of the generator when the end of the voltage dip is detected according to a selected torque profile wherein the selected torque profile is selected from a plurality predetermined torque profiles, wherein the predetermined torque profiles describe torque as a function of time; and wherein the selected torque profile is selected based on the determined acceleration of the rotor of the generator.
An apparatus comprising: a sinusoidally scanning mirror positioned to reflect a light beam, the sinusoidally scanning mirror having an instantaneous scan phase that sweeps through a zero phase value and positive and negative video extents phase values; and a brightness compensation component (340, 740) configured to adjust brightness of the light beam using two functions of the instantaneous scan phase, a first function of the two functions being used when an absolute value of the instantaneous scan phase is below a threshold, and a second function of the two functions being used when an absolute value of the instantaneous scan phase is above the threshold, wherein the threshold corresponds to a knee of a laser class' maximum laser power curve, and wherein each of the first function and the second function is shaped to compensate for brightness variations caused by the varying speed of the sinusoidally scanning mirror. a sinusoidally scanning mirror positioned to reflect a light beam, the sinusoidally scanning mirror having an instantaneous scan phase that sweeps through a zero phase value and positive and negative video extents phase values; and a brightness compensation component (340, 740) configured to adjust brightness of the light beam using two functions of the instantaneous scan phase, a first function of the two functions being used when an absolute value of the instantaneous scan phase is below a threshold, and a second function of the two functions being used when an absolute value of the instantaneous scan phase is above the threshold, wherein the threshold corresponds to a knee of a laser class' maximum laser power curve, and wherein each of the first function and the second function is shaped to compensate for brightness variations caused by the varying speed of the sinusoidally scanning mirror.
A clay film comprising a clay, an additive which is present in an amount of 30 wt% or less and a reinforcing material which is present in an amount of 1-10 wt%, each weight ratio thereof is based on the total solid content of the film, the clay film is self-supporting and has flexiblity, heat resistance, and gas impermeability with a gas permeability coefficient with respect to air, oxygen gas, hydrogen gas or helium gas of less than 1 × 10 -12 cm 2 s -1 cmHg -1 at room temperature, and the surface of the film has a surface formed by surface treatment, wherein said clay is a natural clay or synthetic clay is one or more types selected from the group consisting of mica, vermiculite, montmorillonite, iron montmorillonite, beidellite, saponite, hectorite, stevensite and nontronite; wherein said additive is one or more types selected from the group consisting of ethylene glycol, glycerin, epsilon-caprolactam, dextrin, starch, cellulose-based resin, gelatin, agar, flour, gluten, alkyd resin, polyurethane resin, epoxy resin, fluororesin, acrylic resin, methacrylic resin, phenolic resin, polyamide resin, polyester resin, polyimide resin, polyvinyl resin; polyethylene glycol, polyacrylamide, polyethylene oxide, protein, deoxyribonucleic acid, ribonucleic acid, polyamino acid, phenols and benzoic acid compounds; wherein said reinforcing material is one or more types selected from the group consisting of mineral fibers, glasswool, carbon fibers, ceramic fibers, plant fibers and organic polymer fibers; wherein said surface treatment forms on the surface of the film one or more type selected from a fluorine-based film, silicon-based film, polysiloxane film, fluorine-containing organopolysiloxane film, acrylic resin film, vinyl chloride resin film, polyurethane film, water-repellent plating film, metal vapor deposition film or carbon vapor deposition film.
Silicon-containing, biodegradable material for use in preventing and/or for treating diseases that are associated with increased interleukin-1β and/or interleukin-6 and/or interleukin-8 activity and/or diseases in which a reduction in the activity of Interleukin-1β and/or interleukin-6 and/or interleukin-8 is beneficial for the healing process, wherein the silicon-containing, biodegradable material is a polyhydroxysilicic acid ethyl ester compound of the general formula H[OSi 8 O 12 - x (OC 2 H 5) 6-x] n OH, in which x represents 2 to 5 and n > 1, wherein the diseases are selected from the group of: autoimmune diseases, enteritis, colitis, gastritis, arthritis, myocarditis, dermatitis, otitis, pneumonitis, shock lung, blood clotting disorders, inflammatory bone and joint diseases, rheumatoid arthritis, sepsis, septic shock, post-transplantation sequelae, acute and chronic inflammations, inflammatory bowel disease, graft-versus-host disease, shock, stroke, acute respiratory syndrome (ARDS), psoriasis, restenosis, AIDS, cachexia, cerebrocranial trauma, allergy, parasitic infection, allergic rhinitis, allergic asthma, multiple sclerosis, systemic lupus erythematosus, graft-versus-host disease, transplant rejection, asthma and chronic obstructive pulmonary disease, chronic gastritis, acute and chronic inflammations of the skin, skin allergies, parasitic skin infection, atopic dermatitis in particular neurodermatitis, dermatomyositis, pemphigus vulgaris and/or other local and systemic infections and/or acute and chronic inflammatory situations, with the proviso that wound defects, such as chronic diabetic-neuropathic ulcer, chronic leg ulcer, bedsores, secondary-healing infected wounds, nonirritating, primary-healing wounds, such as in particular ablative lacerations or abrasions, are excluded. autoimmune diseases, enteritis, colitis, gastritis, arthritis, myocarditis, dermatitis, otitis, pneumonitis, shock lung, blood clotting disorders, inflammatory bone and joint diseases, rheumatoid arthritis, sepsis, septic shock, post-transplantation sequelae, acute and chronic inflammations, inflammatory bowel disease, graft-versus-host disease, shock, stroke, acute respiratory syndrome (ARDS), psoriasis, restenosis, AIDS, cachexia, cerebrocranial trauma, allergy, parasitic infection, allergic rhinitis, allergic asthma, multiple sclerosis, systemic lupus erythematosus, graft-versus-host disease, transplant rejection, asthma and chronic obstructive pulmonary disease, chronic gastritis, acute and chronic inflammations of the skin, skin allergies, parasitic skin infection, atopic dermatitis in particular neurodermatitis, dermatomyositis, pemphigus vulgaris and/or other local and systemic infections and/or acute and chronic inflammatory situations, with the proviso that wound defects, such as chronic diabetic-neuropathic ulcer, chronic leg ulcer, bedsores, secondary-healing infected wounds, nonirritating, primary-healing wounds, such as in particular ablative lacerations or abrasions, are excluded.
A method in a wireless device for performing a random access to a cell of a wireless network, the method comprising: - receiving information from a radio network node comprised in the wireless network, wherein the received information indicates a first and a second random access transmission configuration, - selecting one of the first and second random access transmission configurations, - transmitting a random access preamble in accordance with the selected random access transmission configuration, - monitoring to detect a random access response within a first time window when the first random access transmission configuration is selected, and - monitoring to detect the random access response within a second time window when the second random access transmission configuration is selected, wherein the second time window overlaps with at least one low-interference subframe associated with a neighbor cell. - receiving information from a radio network node comprised in the wireless network, wherein the received information indicates a first and a second random access transmission configuration, - selecting one of the first and second random access transmission configurations, - transmitting a random access preamble in accordance with the selected random access transmission configuration, - monitoring to detect a random access response within a first time window when the first random access transmission configuration is selected, and - monitoring to detect the random access response within a second time window when the second random access transmission configuration is selected, wherein the second time window overlaps with at least one low-interference subframe associated with a neighbor cell.